Safety events vary among different opioids
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
New Guidance for Rheumatologists who Treat JIA
Evidence and consensus-based recommendations reflects current knowledge about initiation of therapy
Rheum with a View
Panush’s perspectives on selections from the literature
He Taught Us to Always Go Deeper
Eng Tan, MD, promotes translation from bench to bedside
Advocate from Your Office the Week of March 14
The ACR is urging the 112th Congress to address many issues important to rheumatology including appropriate reimbursement for specialty care, the repeated battle to avert Medicare payment cuts, funding for the pediatric subspecialty loan repayment program, continued fair reimbursement for dual-energy X-ray absorptiometry scans, and the need for increased research funding.
A Huge Thank You to 251 People
RheumPAC supporters are helping to advance rheumatology
Arthritis Foundation Honors Excellence in Rheumatology
AF award recipients include renowned investigator and professor emeritus
Experts Tackle Tough Pain Challenges
NIH conference brings together experts to discuss pain treatment
The DMOAD Dream a Generation Later
Few effective treatments for OA have been developed, and the approach to clinical trials might need modifications
BATTER-UP Takes Swing at Potential RA Biomarkers
Ongoing study aims to identify patients unlikely to respond to anti-TNF drugs
- « Previous Page
- 1
- …
- 212
- 213
- 214
- 215
- 216
- …
- 246
- Next Page »